Thursday, December 19, 2019

Reflections from an HIV Advocate's Journey: Jonathan J. Pena

›
By: Jonathan J. Pena, senior in social work, North Carolina State University Eckhart Tolle once wrote, “Acceptance looks like a passive s...
Thursday, December 12, 2019

Now a chronic disease, HIV is turning gray

›
By: Jeffrey R. Lewis On June 5, 1981, a new public health threat reared its ugly head in the United States: five cases of Pneumocystiscari...
Thursday, December 5, 2019

FDA Approves New Injectable Naloxone

›
By: Marcus J. Hopkins, Policy Consultant The U.S. Food & Drug Administration (FDA) has approved a new injectable form of naloxone hydr...
Thursday, November 21, 2019

Web Pharmacy Sites Offered Antibiotics Cancer & HIV Treatments Along with Counterfeit Opioids

›
By: Shabbir J. Safdar, Executive Director, The Partnership for Safe Medicines Reprinted with permission from The Partnership for Safe Medi...
Thursday, November 14, 2019

Transportation Assistance Survey from the PAN Foundation

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association The Patient Access Network (PAN) Foundation launched a transportation assistance pi...
Thursday, November 7, 2019

Molecular HIV surveillance: public health tool or weapon?

›
By: Jeffrey R. Lewis There is a longstanding, inherent value in the assurance of privacy in our healthcare system. Among other things, it ...
Thursday, October 31, 2019

Reflections from an HIV Advocate's Journey: Mark Janes

›
By: Mark Janes, California Advocate My journey with HIV began in 1995, and I still remember the first time I discussed AIDS publicly, in a...